Rockwell Medical, Inc. (NASDAQ:RMTI) Q3 2022 Earnings Conference Call November 14, 2022 8:00 AM ET
Company Participants
Heather Hunter - SVP & Chief Affairs Officer
Mark Strobeck - President, CEO & Director
Paul McGarry - Senior Vice President, Finance and Chief Accounting Officer
Conference Call Participants
Brandon Folkes - Cantor Fitzgerald & Co.
Raghuram Selvaraju - HC Wainwright & Co.
Operator
Good morning, and welcome to Rockwell Medical's Third Quarter 2022 Results Conference Call and Webcast. Please note, this event is being recorded.
At this time, I would like to turn the conference call over to Heather Hunter, Senior Vice President, Chief Affairs Officer at Rockwell Medical. Heather please go ahead.
Heather Hunter
Good morning, and thank you for joining us for this update on Rockwell Medical. Joining me on today's conference call are Dr. Mark Strobeck, Rockwell's President and Chief Executive Officer; and Paul McGarry, Rockwell Medical's Senior Vice President, Finance and Chief Accounting Officer. During today's call, Mark will discuss changes we are making to Rockwell Medical's corporate strategy along with the recent company update and then review highlights from the third quarter. Then Paul will go through Rockwell's financial results. After that, we will open the lines to take your questions.
Before we begin, I would like to remind everyone that this conference call will contain forward-looking statements about Rockwell Medical within the meaning of the federal securities laws including, but not limited to, the types of statements identified as forward-looking in our annual report on Form 10-K and our subsequent periodic reports filed with the SEC which are all available on our Web site under the Investors section. These statements are subject to risks and uncertainties that could cause actual results to differ.
Please note that these forward-looking statements reflect our opinions and expectations only as of today. Except as required by law, we specifically disclaim any obligation to update or revise these forward-looking statements in light of new information or future events. Factors that could cause actual results or outcomes to differ materially from those expressed in or implied by such forward-looking statements are discussed in greater detail in our periodic reports filed with the SEC. Rockwell Medical's quarterly report on Form 10-Q for the quarterly period ended September 30, 2022 will provide a full analysis of the company's business strategy as well as the company's third quarter 2022 results. The Form 10-Q for the third quarter of 2022 will be filed at the conclusion of this call. Additionally, a recording of this conference call will be available on Rockwell Medical's Web site under the Investors section.